Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia — Stella

Home/Chronic Lymphocytic Leukemia/Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia

View on ClinicalTrials.gov

Recruiting

Back to Chronic Lymphocytic Leukemia trials

Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Ohio State University Comprehensive Cancer Center, Columbus, Ohio

Key details

Phase

Safety & dosing

Sponsor

Seema Bhat

Enrollment target

~80 participants

Started

September 2023

Primary completion

October 2026

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.